Skip to main content
main-content

The continuing evolution of GLP-1RAs

Live webinar

Join Professor John Wilding on Wednesday May 8 at 19:00-20:00 (BST) for a live webinar discussion on the continuing evolution of glucagon-like peptide-1 receptor agonists. Register now 

During the live webinar, the expert panel will discuss:

  • The importance of early and effective treatment to reduce the risk of complications and avoid clinical inertia.
  • The appropriate use of the different once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) formulations.
  • The next generation, non-injectable GLP-1RAs and the role they will play in the management of type 2 diabetes.

You will have the opportunity to pose questions to our panel of experts throughout the session, and interact by answering live questions to promote peer-to-peer engagement and debate.

© Springer Healthcare IME

Target audience

This webinar is suitable for, but not limed to, diabetes specialists, primary care physicians, specialist diabetes nurses, cardiologists, and all other healthcare professionals interested in the treatment of type 2 diabetes.

Learning objectives

Following this educational activity participants will be able to:

  1. Discuss the importance of timely treatment of type 2 diabetes and its impact on patient health and outcomes.
  2. Compare the efficacy and safety profiles of once weekly GLP-1RAs.
  3. Explain the next generation of GLP-1RAs including the mode of absorption, mechanism of action, dosing schedule, pharmacokinetic/pharmacodynamic properties, glycemic/weight loss efficacy and safety.

Faculty

Agenda

19:00-19:05

Welcome and introduction

19:05-19:20

The importance of timely treatment of T2D

19:20-19:40

Once weekly GLP-1RAs – which one and when?

19:40-19:55

Next generation GLP-1RAs

19:55-20:00

Final comments and close

Accreditation

The continuing evolution of GLP-1RAs webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

© Springer Healthcare IME

Educational grant

This program is made possible thanks to an independent educational grant from Novo Nordisk A/S.

Contact us

Email: IME@springer.com
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK 
SH IME